Skip to Main Content

++

An understanding of the remarkable cardiovascular changes during a normal pregnancy is important for optimal care. Failure to recognize and treat heart disease when it exists can adversely affect both the mother and the child.

++

Health Priorities

++

The health of the developing fetus is predominantly determined by the health of the mother. When treating heart disease, the health of the fetus should be considered, but the safety of the mother is the highest priority. Ideally, treatment of the mother with drugs, diagnostic studies, or surgery should be avoided unless required for maternal safety.

++

Maternal Fragility

++

Heart disease is the second most common cause of maternal death in Western countries (suicide is first).1 Sometimes the risk is sufficient to recommend avoidance or interruption of pregnancy (Table 97–1).

++
Table Graphic Jump Location
Table 97–1. Cardiovascular Abnormalities Placing a Mother and Infant at Extremely High Risk
++

Fetal Vulnerability

++

The maternal commitment to the fetus is exceptional, but if the mother requires a redistribution of blood flow for her own safety, blood is preferentially diverted away from the uterus. This subjects the fetus to an insufficient supply of oxygen and nutrients and ineffective removal of metabolic waste and heat. Uterine blood flow can already be compromised in a woman with heart disease, increasing the possibility of inadequate uterine perfusion. Treatment of maternal heart disease can also jeopardize the fetus. Diagnostic studies, drugs, or surgery may increase fetal loss, result in teratogenicity, or alter fetal growth.

++

Newborn Infant Vulnerability

++

The health of a newborn infant is a concern when the mother has heart disease. This fragility can be caused by a marginal uterine blood flow during pregnancy or by lingering effects of the medications used to treat the mother. Additionally, there is an increased incidence of congenital heart disease among the live-born infants of parents with congenital heart disease. Early infant nourishment may be jeopardized if maternal heart disease is severe enough to interfere with breastfeeding. Even if the mother is capable of breastfeeding, cardiovascular medications can be transmitted to the infant in the breast milk. Finally, the infant is at risk of losing a parent because life expectancy with many forms of heart disease is significantly reduced.

++

Effects of Previous Treatment

+...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessCardiology Full Site: One-Year Subscription

Connect to the full suite of AccessCardiology content and resources including textbooks such as Hurst's the Heart and Cardiology Clinical Questions, a unique library of multimedia, including heart imaging, an integrated drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessCardiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.